Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Daxor Announces It Has Submitted Its Blood Volume Analyzer, Daxor BVA, To The FDA

Author: Benzinga Newsdesk | January 02, 2024 09:33am

The New BVA System is Designed to be Significantly Faster, Simpler and Give Results at the Bedside

Potential clearance is expected during the first half of 2024. The Company's mission is to advance healthcare by enabling optimal fluid management.

Posted In: DXR